Epilepsy Research
Volume 32, Issue 1 , Pages 12-23 , 1 September 1998

Tuberous sclerosis-related gene expression in normal and dysplastic brain

  • Harry V Vinters

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), UCLA Medical Center, Los Angeles, CA 90095, USA
    • Brain Research Institute and Mental Retardation Research Center, UCLA, Los Angeles, CA 90095, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 310 8256191; fax: +1 310 2068290; e-mail hvinters@pathology.medsch.ucla.edu
    • ,
  • Christopher Kerfoot

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), UCLA Medical Center, Los Angeles, CA 90095, USA
    • ,
  • Michael Catania

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), UCLA Medical Center, Los Angeles, CA 90095, USA
    • ,
  • Jessica K Emelin

      Affiliations

    • Department of Pathology and Laboratory Medicine (Neuropathology), UCLA Medical Center, Los Angeles, CA 90095, USA
    • ,
  • Steven N Roper

      Affiliations

    • Department of Neurological Surgery, University of Florida, College of Medicine, Gainesville, FL 32610, USA
    • ,
  • Jeffrey E DeClue

      Affiliations

    • Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA

References 

  1. Barinaga M. Guiding neurons to the cortex. Science. 1996;274:1100–1101
  2. Becker LE. Synaptic dysgenesis. Can. J. Neurol. Sci. 1991;18:170–180
  3. Bronen RA, Vives KP, Kim JH, Fulbright RK, Spencer SS, Spencer DD. Focal cortical dysplasia of Taylor, balloon cell subtype: MR differentiation from low-grade tumors. AJNR Am. J. Neuroradiol. 1997;18:1141–1151
  4. Carbonara C, Longa L, Grosso E, Borrone C, Garrè MG, Brisigotti M, et al. 9p34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum. Mol. Genet. 1994;3:1829–1832
  5. Clark GD, Mizuguchi M, Antalffy B, Barnes J, Armstrong D. Predominant localization of the LIS family of gene products to Cajal-Retzius cells and ventricular neuroepithelium in the developing human cortex. J. Neuropathol. Exp. Neurol. 1997;56:1044–1052
  6. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J. Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathology. Proc. Natl. Acad. Sci. USA. 1996;93:14152–14157
  7. De Rosa MJ, Secor DL, Barsom M, Fisher RS, Vinters HV. Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathol. 1992;84:250–260
  8. Duong T, De Rosa MJ, Poukens V, Vinters HV, Fisher RS. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol. 1994;87:493–503
  9. Farrell MA, De Rosa MJ, Curran JG, Secor DL, Cornford ME, Comair YG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol. 1992;83:246–259
  10. Geist RT, Gutmann DH. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Diff. 1995;6:1477–1483
  11. Geist RT, Reddy AJ, Zhang J, Gutmann DH. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues. Neurobiol. Dis. 1996;3:111–120
  12. Green AJ, Johnson PH, Yates JRW. The tuberous sclerosis gene on chromosome 9p34 acts as a growth suppressor. Hum. Mol. Genet. 1994;3:1833–1834
  13. Green AJ, Smith M, Yates JRW. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet. 1994;6:193–196
  14. Guerrini, R., Canapicchi, R., Zifkin, B.G., Andermann, F., Roger, J., Pfanner, P. (Eds.), 1996. Dysplasias of Cerebral Cortex and Epilepsy. Lippincott–Raven, Philadelphia–New York.
  15. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet. 1996;59:400–406
  16. Hino O, Kobayashi E, Hirayama Y, Kobayashi T, Kubo Y, Tsuchiya H, et al. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Mol. Carcinogenesis. 1995;14:23–27
  17. Jay V, Becker LE. Surgical pathology of epilepsy: A review. Pediatric Pathol. 1994;14:731–750
  18. Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC, Welsh CT, et al. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol. 1996;6:367–377
  19. Kuzniecky RI, Barkovich AJ. Pathogenesis and pathology of focal malformations of cortical development and epilepsy. J. Clin. Neurophysiol. 1996;13:468–480
  20. Lo Nigro C, Chong SS, Smith ACM, Dobyns WB, Carrozzo R, Ledbetter DH. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum. Mol. Genet. 1997;6:157–164
  21. Lopes MBS, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol. 1996;91:368–375
  22. Menchine M, Emelin JK, Mischel PS, Haag TA, Norman MG, Pepkowitz SH, et al. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod. Pathol. 1996;9:1071–1080
  23. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J. Neuropathol. Exp. Neurol. 1995;54:137–153
  24. Mizuguchi M, Takashima S, Kakita A, Yamada M, Ikeda K. Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome. Am. J. Pathol. 1995;147:1142–1151
  25. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann. Neurol. 1996;40:941–944
  26. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol. 1997;94:525–531
  27. Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y, Andermann E, et al. Focal neuronal migration disorders and intractable partial epilepsy: A study of 30 patients. Ann. Neurol. 1991;30:741–749
  28. Park S-H, Pepkowitz SH, Kerfoot C, De Rosa MJ, Poukens V, Wienecke R, et al. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol. 1997;94:180–186
  29. Platten M, Meyer-Puttlitz B, Blümcke I, Waha A, Wolf HK, Nöthen MM, et al. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. J. Neuropathol. Exp. Neurol. 1997;56:806–810
  30. Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 1993;364:717–721
  31. Roper SN, Gilmore RL, Houser CR. Experimentally induced disorders of neuronal migration produce an increased propensity for electrographic seizures in rats. Epilepsy Res. 1995;21:205–219
  32. Rorke LB. The role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J. Neuropathol. Exp. Neurol. 1994;53:105–117
  33. Ross ME, Allen KM, Srivastava AK, Featherstone T, Gleeson JG, Hirsch B, et al  Linkage and mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain. Hum. Mol. Genet. 1997;6:555–562
  34. Sampson JR, Harris PC. The molecular genetics of tuberous sclerosis. Hum. Mol. Genet. 1994;3:1477–1480
  35. Sarnat HB. Cerebral dysplasias as expressions of altered maturational processes. Can. J. Neurol. Sci. 1991;18:196–204
  36. Taylor DC, Falconer MA, Bruton CJ, Corsellis JAN. Focal dysplasia of the cerebral cortex in epilepsy. J. Neurol. Neurosurg. Psychiatry. 1971;34:369–387
  37. The European Chromosome 16 Tuberous Sclerosis Consortium . Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305–1315
  38. Trottier S, Evrard B, Vignal J-P, Scarabin J-M, Chauvel P. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res. 1996;25:79–106
  39. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277:805–808
  40. Vinters HV, Fisher RS, Cornford ME, Mah V, Secor DL, DeRosa MJ, et al. Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Child Nerv. Syst. 1992;8:8–17
  41. Vinters HV, De Rosa MJ, Farrell MA. Neuropathologic study of resected cerebral tissue from patients with infantile spasms. Epilepsia. 1993;34:772–779
  42. Vinters HV, Kerfoot C, Emelin JK. Tuberin loss from cerebral tissues. Ann. Neurol. 1997;42:270–271
  43. Wienecke R, König A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 1995;270:16409–16414
  44. Wienecke R, Maize JC, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, et al. Co-localization of the TSC2 product tuberin with its target Rap1 in the golgi apparatus. Oncogene. 1996;13:913–923
  45. Wienecke R, Guha A, Maize JC, Heideman RL, DeClue JE, Gutmann DH. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Ann. Neurol. 1997;42:230–235
  46. Wienecke R, Maize JC, Reed JA, de Gunzburg J, Yeung RS, DeClue JE. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am. J. Pathol. 1997;150:43–50
  47. Wilson PJ, Ramesh V, Kristiansen A, Bove C, Jozwiak S, Kwiatkowski DJ, et al. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum. Mol. Genet. 1996;5:249–256
  48. Wolf HK, Zentner J, Hufnagel A, Campos MG, Schramm J, Elger CE, et al. Surgical pathology of chronic epileptic seizure disorders: experience with 63 specimens from extratemporal corticectomies, lobectomies and functional hemispherectomies. Acta Neuropathol. 1993;86:466–472
  49. Wolf HK, Normann S, Green AJ, von Bakel I, Blumcke I, Pietsch T, et al. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol. 1997;93:93–96
  50. Xu L, Sterner C, Maheshwar MM, Wilson PJ, Nellist M, Short PM, et al. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics. 1995;27:475–480
  51. Yeung RS, Xiao G-H, Everitt JI, Jin F, Walker CL. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol. Carcinogenesis. 1995;14:28–36

PII: S0920-1211(98)00036-9

Epilepsy Research
Volume 32, Issue 1 , Pages 12-23 , 1 September 1998

Article Tools

* Image Usage & Resolution